Coheres Biosciences Inc
Coherus Biosciences Inc., based in Camarillo, CA, is dedicated to advancing innovative cancer therapeutics with a focus on next-generation combination therapies and immuno-oncology. Their portfolio includes FDA-approved treatments and a pipeline of investigational drug candidates aimed at improving outcomes for patients with challenging tumors.
Through ongoing clinical trials, Coherus is committed to evaluating the safety and effectiveness of its immuno-oncology drugs, including the anti-PD-1 monoclonal antibody LOQTORZI (toripalimab-tpzi). The company aims to transform cancer treatment and extend survival rates for patients dealing with hard-to-treat malignancies.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.